Nausea & vomiting in adults — antiemetic choice by cause (mechanism-based antiemetics)
Bedside summary
Rational antiemetic prescribing matches the drug to the dominant emetic pathway/receptor driving the nausea. Key pathways: chemoreceptor trigger zone (D2, 5-HT3 — drugs, toxins, metabolic/biochemical e.g. hypercalcaemia, uraemia, opioids); gut/vagal (5-HT3, D2 — gastric stasis, obstruction, chemo/radiotherapy); vestibular (H1, muscarinic — motion, vertigo); cortical (anxiety, pain, raised ICP); and gastric stasis (prokinetic required). Identify and treat the cause, choose the matched antiemetic, use the parenteral/SC route if vomiting, and review before combining or escalating.
Red flags
- Vomiting with severe abdominal pain/distension, no flatus/stool — bowel obstruction/perforation
- Headache, papilloedema, focal neurology, early-morning vomiting — raised ICP
- Haematemesis / coffee-ground vomiting — GI bleed
- Features of DKA, hypercalcaemia, uraemia, pregnancy (exclude), or sepsis
- Signs of significant dehydration / shock / AKI from protracted vomiting
Assessment
Differential diagnosis
- Drugs/toxins/metabolic (opioids, chemo, antibiotics; hypercalcaemia, uraemia, DKA, hyponatraemia, hepatic/renal failure) — CTZ (D2/5-HT3)
- Gastric stasis / gastroparesis / functional dyspepsia / partial obstruction — prokinetic (D2)
- Bowel obstruction (complete/mechanical) — avoid prokinetic if colic; antisecretory
- Raised intracranial pressure (tumour, bleed) — cyclizine +/- dexamethasone
- Vestibular (labyrinthitis, BPPV, motion, Meniere) — H1/antimuscarinic
- Chemotherapy/radiotherapy-induced (5-HT3, NK1, steroid)
- Anxiety/anticipatory (cortical) — benzodiazepine
- Pregnancy (manage per hyperemesis pathway), gastroenteritis, post-operative (PONV)
Investigations
- Identify cause: history (timing, relation to meals/opioids/movement), drug chart, bowel habit
- Examination: abdomen (distension, succussion splash, obstruction), neuro (papilloedema, focal signs), hydration status
- Bloods: U&E, calcium, glucose, LFTs, (amylase/lipase, bHCG, drug levels e.g. digoxin as indicated)
- Erect abdominal/chest X-ray or CT if obstruction/perforation suspected
- Assess for dehydration and electrolyte disturbance from vomiting (hypokalaemia, metabolic alkalosis)
Management
- Correct reversible causes: stop/rotate culprit drug, correct hypercalcaemia/hyponatraemia/DKA, relieve obstruction, treat infection, treat constipation
- Rehydrate and replace electrolytes (IV fluids + potassium as needed)
- Choose antiemetic by mechanism (see drugs); if vomiting, give IV or SC — oral absorption is unreliable
- Chemical/metabolic/opioid-induced: haloperidol first-line (or metoclopramide/ondansetron)
- Gastric stasis/prokinetic needed: metoclopramide or domperidone (avoid if complete obstruction/colic/perforation)
- Raised ICP / bowel obstruction (no prokinetic): cyclizine; add dexamethasone for ICP or obstruction
- Vestibular: cyclizine or an antihistamine/antimuscarinic (prochlorperazine, hyoscine)
- Chemo-induced: 5-HT3 antagonist (ondansetron) + dexamethasone +/- NK1 antagonist (aprepitant)
- Unknown/multiple causes or refractory: broad-spectrum levomepromazine
- Combine drugs with complementary (not duplicate) receptor actions; review at 24-48 h before escalating
Drugs & doses
Disposition
Complications & pitfalls
- Dehydration, AKI, hypokalaemia and metabolic alkalosis
- Aspiration pneumonia, Mallory-Weiss tear, oesophageal rupture
- Drug side effects: extrapyramidal/dystonia (metoclopramide, prochlorperazine), QT prolongation (ondansetron, haloperidol, domperidone), constipation (ondansetron)
- Malnutrition if prolonged
Exam pearls
- Match the drug to the receptor/cause: haloperidol for chemical/metabolic, metoclopramide for stasis, cyclizine for vestibular/ICP/obstruction, ondansetron for chemo/post-op, levomepromazine when unknown/refractory.
- If the patient is vomiting, give antiemetics parenterally (IV or SC) — not orally.
- Avoid prokinetics (metoclopramide/domperidone) in complete mechanical bowel obstruction or with colic.
- Do not combine two drugs with the same receptor action (e.g. cyclizine + hyoscine both antimuscarinic; cyclizine antagonises metoclopramide's prokinetic effect).
- Guidance: Palliative Care Formulary, Scottish Palliative Care Guidelines, NICE CKS N&V. Evidence that cause-based selection beats empirical is weak but it is standard, rational practice.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.